Literature DB >> 25227301

Exclusive enteral nutrition: clues to the pathogenesis of Crohn's disease.

Arie Levine1.   

Abstract

Crohn's disease (CD) is a complex inherited disorder of unknown pathogenesis. Recent evidence suggests that CD may involve genetic or environmental factors that impair the normal innate immune system's ability to contain bacteria to the lumen. Multiple dietary components may impact on the resident flora, diminish or damage the mucous layer, increase intestinal permeability or increase the ability of pathobionts to adhere to epithelial cells or translocate across the epithelial barrier. This chapter reviews the possible effects of different dietary components present in the Western diet to affect bacterial clearance mechanisms, and offers a hypothetical model for an acquired bacterial clearance defect in CD. 2014 Nestec Ltd., Vevey/S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25227301     DOI: 10.1159/000360719

Source DB:  PubMed          Journal:  Nestle Nutr Inst Workshop Ser        ISSN: 1664-2147


  4 in total

1.  [Protective effect of procyanidin B2 on intestinal barrier and against enteritis in a mouse model of trinitrobenzene sulphonic acid-induced colitis].

Authors:  Congqiao Jiang; Pingsheng Zhu; Yi Shi; Wujun Xiang; Sitang Ge; Zongbing Zhang; Lugen Zuo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30

2.  Importance of nutritional therapy in the management of intestinal diseases: beyond energy and nutrient supply.

Authors:  Seong-Eun Kim
Journal:  Intest Res       Date:  2019-09-04

Review 3.  Nutritional Therapy Strategies in Pediatric Crohn's Disease.

Authors:  Charlotte M Verburgt; Mohammed Ghiboub; Marc A Benninga; Wouter J de Jonge; Johan E Van Limbergen
Journal:  Nutrients       Date:  2021-01-13       Impact factor: 5.717

4.  A new method for quantitative detection of Lactobacillus casei based on casx gene and its application.

Authors:  Xiaoyang Pang; Ziyang Jia; Jing Lu; Shuwen Zhang; Cai Zhang; Min Zhang; Jiaping Lv
Journal:  BMC Biotechnol       Date:  2019-12-10       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.